A Systematic Overview of Radiation Therapy Effects in Non-Hodgkin's Lymphoma

References

• National Board of Health and Welfare, Sweden. Cancer incidence in Sweden 2000. Stockholm: National Board of Health and Welfare, Centre for Epidemiology, The Cancer Registry, 2001.
   Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92. (O1)
   PubMedGoogle Scholar
• Harris NL, Jaffe ES, Diebold J, et al. Lymphoma classification-from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol 2000; 11: 3–10. (O1)
   Google Scholar
• Hiddemann W, Longo DL, Coiffier B, et al. Lymphoma classification-the gap between biology and clinical manage-ment is closing. Blood 1996; 88: 4085-9. (O1)
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Fac-tors Project: a predictive model of aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-94. (R1/2031)
   Google Scholar
• Glick JH, Kim K, Earle J, et al. An ECOG randomized phase III trial of CHOP vs CHOP +radiotherapy (XRT) for inter-mediate grade early stage non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1995; 14: 391. (Abstr.)
   Google Scholar
• Shchepotin IB, Evans SRT, Shabahang M, et al. Primary non-Hodgkin's lymphoma of the stomach: three radical modalities of treatment in 75 patients. Ann Surg Oncol 1996; 3: 277–84.
   PubMed Web of Science ®Google Scholar
• Pendlebury S, El Awadi M, Ashley, et al. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. Radiother Oncol 1995; 36: 167-71. (R3/40)
   Google Scholar
• MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14: 1282-90. (R2/177)
   Google Scholar
• Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lym-phoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994; 69: 1088-93. (R1/451)
   Google Scholar
• Kamath SS, Marcus RB, Jr, Lynch JW, Mendenhall NP. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1999; 44: 563-8. (R2/285)
   Google Scholar
• Soubeyran P, Eghbali H, Trojani M, et al. Is there any place for a wait-and-see policy in stage 10 follicular lymphoma? A study of 43 consecutive patients in a single center. Ann Oncol 1996; 7: 713-8. (P3/26)
   Google Scholar
• Stuschke M, Hoederath A, Sack H, et al. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas. Re-sults of a prospective multicenter study. Cancer 1997; 80: 2273-84. (P2/100)
   Google Scholar
• De Los Santos JF, Mendenhall NP, Lynch JW. Is comprehen-sive lymphatic irradiation for low-grade non-Hodgkin's lym- phoma curative therapy? Long-term experience at a singleinstitution. Int J Radiat Oncol Biol Phys 1997; 38: 3-8. (R3/21)
   Google Scholar
• Kelsey SM, Newland AC, Vaughan Hudson G, Jelliffe AM. A British National Lymphoma Investigation randomized trial of single agent chlorambucil plus radiotherapy versus radiother-apy alone in low grade, localized non-Hodgkin's lymphoma. Med Oncol 1994; 11: 19-25. (C3/148)
   Google Scholar
• Denham JW, Denham E, Dear KB, Hudson GV. The follicular non-Hodgkin's lymphomas-I. The possibility of cure. Eur J Cancer 1996; 32A: 470–9. (C3/-)
   Google Scholar
• Brandt L, Kimby E, Nygren P, et al. A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma. Acta Oncol 2001; 40: 213–23.
   PubMed Web of Science ®Google Scholar
• Girinsky T, Guillot-Vals D, Koscielny S, et al. A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of pre-dictive parameters of response to treatment. Int J Radiat Oncol Biol Phys 2001; 51: 148-55. (R2/48)
   Google Scholar
• Osterman B, Cavallin-Stähl E, Hagberg H, et al. High-grade non-Hodgkin's lymphoma stage I. A retrospective study of treatment, outcome and prognostic factors in 213 patients. Acta Oncol 1996; 35: 171–7. (R1/213)
   Google Scholar
• Fuller LM, Krasin MJ, Velasquez WS, et al. Significance of tumour size and radiation dose to local control in stage I-III large cell lymphoma treated with CHOP-bleo and radiation. Int J Radiat Oncol Biol Phys 1995; 31: 3-11. (P2/146)
   Google Scholar
• van der Maazen RWM, Noordijk EM, Thomas J, et al. Combined modality treatment is the treatment of choice for stage HE intermediate and high grade non-Hodgkin's lym-phomas. Radiother Oncol 1998; 49: 1-7. (R2/296)
   Web of Science ®Google Scholar
• Oguchi M, Ikeda H, Isobe K, et al. Tumour bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan lymphoma radiation therapy group. Int J Radiat Oncol Biol Phys 2000; 48: 161-8. (R1/787)
   Google Scholar
• Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21-6. (C1/401)
   Google Scholar
• Miller TP, Leblanc M, Spier C, et al. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial. Blood 2001; 98: abstract 3024.
   Google Scholar
• Munck JN, Dhermain F, Koscielny S, et al. Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumours 5 cm. Ann Oncol 1996; 7: 925-31. (P2/96)
   Google Scholar
• Freilone R, Botto B, Vitolo U, et al. Combined modality treatment with a weekly brief chemotherapy (ACOP-B) fol-lowed by locoregional radiotherapy in localized-stage inter-mediate- to high-grade non-Hodgkin's lymphoma. Ann Oncol 1996; 7: 919-24. (P2/84)
   Google Scholar
• Kimby E, Brandt L, Nygren P, et al. A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma. Acta Oncol 2001; 40: 198–212.
   PubMed Web of Science ®Google Scholar
• Aviles A, Delgado S, Nambo M J, et al. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. Int J Radiat Oncol Biol Phys 1994; 30: 799-803. (C3/88)
   Google Scholar
• Ferreri AJM, Dell'Oro S, Reni M, et al. Consolidation radio-therapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas. Oncology 2000; 58: 219-26. (R2/94)
   Google Scholar
• Richaud PM, Soubeyran P, Eghbali H, et al. Place of low dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study. Int J Radiat Oncol Biol Phys 1998; 40: 387-90. (P3/26)
   Google Scholar
• Safwat A. The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method. Radiother Oncol 2000; 56: 1-8. (L1)
   PubMed Web of Science ®Google Scholar
• Travis LB, Weeks J, Curtis RE, et al. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodg-kin's lymphoma. J Clin Oncol 1996; 14: 565-71. (R2/61)
   Google Scholar
• Mahe M-A, Bourdin S, Le Pourhiet-Le Mevel A, et al. Salvage extended-field irradiation in follicular non-Hodgkin's lym-phoma after failure of chemotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 735–8. (R3/34)
   Google Scholar
• Apostolidis J, Gupta RK, Grenzelias D, et al. High-dose therapy with autologous bone marrow support as consolida-tion of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin Oncol 2000; 18: 527-36. (R1/99)
   Google Scholar
• Mounier N, Gisselbrecht C. Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 1998; 9: 15-21. (L1)
   Google Scholar
• Aristei C, Tabilo A. Total-body irradiation in the conditioning regimens for autologous stem cell transplantation in lympho-proliferative diseases. Oncologist 1999; 4: 386-97. (L1)
   PubMedGoogle Scholar
• Milligan DW, Ruiz de Elvira MC, Kolb HJ, et al. Secondary leukaemia and myelodysplasia after autografting for lym-phoma: results from the EBMT. Br J Haematol 1999; 106: 1020-6. (R1/4998)
   Google Scholar
• Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumour diagnosed in the year 2000? Cancer 1997; 79: 2409-13. (01)
   PubMed Web of Science ®Google Scholar
• Maher EA, Fine HA. Primary CNS lymphoma. Semin Oncol 1999; 26: 346-56. (L1)
   Google Scholar
• Krogh-Jensen M, D'Amore F, Jensen MK, et al. Clinicopatho-logical features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumours in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO and the Danish Cancer Registry. Leuk Lymphoma 1995; 19: 223-33. (O1)
   PubMed Web of Science ®Google Scholar
• Laperriere NJ, Wong CS, Milosevic MF, et al. Accelerated radiation therapy for primary lymphoma of the brain. Radio-ther Oncol 1998; 47: 191-5. (P2/10)
   Google Scholar
• Ferreri AJM, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 2000; 11: 927-37. (L1)
   Google Scholar
• Abrey LE, Yahalom J, DeAngelis LM. Treatment of primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144-50. (P2/52)
   Google Scholar
• Goldkuhl C, Ekman T, Wiklund T, Telhaug R for the Nordic Lymphoma Group. Age-adjusted chemotherapy for primary central-nervous lymphoma - A pilot study. Acta Oncol 2002; 41: 29–35.
   Google Scholar
• Mead GM, Bleehen NM, Gregor A, et al. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma. Cancer 2000; 89: 1359-70. (C3/53)
   Google Scholar
• Reni M, Ferreri AJM, Garancini MP, Villa E. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 1997; 8: 227-34. (L1/676)
   Google Scholar
• Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859-63. (P3/ 31)
   Google Scholar
• O'Brien P, Roos D, Pratt G, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in pri-mary CNS lymphoma. J Clin Oncol 2000; 18: 519-26. (P2/46)
   Google Scholar
• Corry J, Smith JG, Wirth A, et al. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int .1 Radiat Oncol Biol Phys 1998; 41: 615–20. (R3/62)
   PubMed Web of Science ®Google Scholar
• Laperriere NJ, Cerezo L, Milosevic MF, et al. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother Oncol 1997; 43: 247-52. (R3/49)
   Google Scholar
• DeAngelis LM. Primary central nervous system lymphoma: an update. Educational book of the 37th Annual Meeting of the American Society of Clinical Oncology; May 12–15, San Francisco; 2001. p. 277–80. (L1)[G3]
   Google Scholar
• Gospodarowicz MK, Zucca E. Primary testis lymphoma: presentation, treatment, patterns of failure, and outcomes. Educational book of the 37th Annual Meeting of the American Society of Clinical Oncology; May 12–15, San Francisco; 2001. p. 281–5. (L1)[G4]
   Google Scholar
• Zucca E, Conconi A, Mughal T, et al. Patterns of survival in primary diffuse large-cell B-cell lymphoma (DLCL) of the testis. An international survey of 373 patients. Blood 2000; 96: 334a. (Abstr.)
   Google Scholar
• Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 2000; 46: 1093-103. (L1)
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project: a clin-ical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-18. (O1)
   PubMed Web of Science ®Google Scholar
• Isaacson PG. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type. Educational Book of the 37th Annual Meeting of the American Society of Clinical Oncology; May 12–15, San Francisco; 2001. p. 273–6. (L1)
   Google Scholar
• Rohatiner A, on behalf of d'Amore F, Coiffier B, Crowther D, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400. (01)
   Google Scholar
• Zucca E, Roggero E, Bertoni F, Cavalli E Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727–37. (L1)
   Google Scholar
• Isaacson G. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999; 10: 637-45. (01)
   Google Scholar
• Liu H, Ruskone-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lym-phoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001; 357: 39-40. (01/22)
   Google Scholar
• Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997; 89: 1350-5. (P1/50)
   Google Scholar
• de Jong D, Aleman BMP, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 1999; 10: 275-80. (01)
   Google Scholar
• Yahalom J, Schechter JNR, Gonzales M, Portlock CS. Effective treatment of MALT lymphoma of the stomach with radiation alone. Ann Oncol 1999; 10: 135. (Abstr.)
   Google Scholar
• Willich NA, Reinartz G, Horst EJ, et al. Operative and conservative management primary gastric lymphoma: interim results of a German multicenter study. Int J Radiat Oncol Biol Phys 2000; 46: 895-901. (P1/169)
   Google Scholar
• Haim N, Leviov M, Ben-Arieh Y, et al. Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leuk Lymphoma 1995; 17: 321-6. (P3/ 24)
   Google Scholar
• Tondini C, Balzarotti M, Santoro A, et al. Initial chemotherapy for primary respectable large-cell lymphoma of the stomach. Ann Oncol 1997; 8: 497-9. (P3/17)
   Google Scholar
• Fischbach W, Dragosics B, Kolve-Goebeler M-E, et al. for the German-Austrian gastrointestinal study group. Primary gas-tric B-cell lymphoma: results of a prospective multicenter study. Gastroenterology 2000; 119: 1191-202. (P1/236)
   Google Scholar
• Ansell SM, Grant C S, Haberman TM. Primary thyroid lymphoma. Semin Oncol 1999; 26: 316-23. (L1)
   Google Scholar
• Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semin Radiat Oncol 1995; 5: 281-300. (L1)
   PubMedGoogle Scholar
• Laing RW, Hoskin P, Vaughan Hudson B, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol 1994; 6: 300-4. (R2/45)
   Google Scholar
• Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10: 1023–33. (L1)
   Google Scholar
• Aviles A, Delgado S, Ruiz H, et al. Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemother-apy versus combined therapy. Oral Oncol Eur J Cancer 1996; 32B: 19-23. (C2/316)
   Google Scholar
• Yuen A, Jacobs C. Lymphomas of the head and neck. Semin Oncol 1999; 26: 338-45. (L1)
   Google Scholar
• Aviles A, Delgado S, Huerta-Guzman J. Marginal zone B cell lymphoma of the parotid glands: results of a randomized trial comparing radiotherapy to combined therapy. Oral Oncol Eur J Cancer 1996; 32B: 420-2. (C3/39)
   Google Scholar
• Li YX, Coucke PA, Li J-Y, et al. Primary non-Hodgkin's lymphoma of the nasal cavity. Prognostic significance of paranasal extension and the role of radiotherapy and che-motherapy. Cancer 1998; 83: 449-56. (R1/175)
   Google Scholar
• Logsdon MD, Ha CS, Kavadi VS, et al. Lymphoma of the nasal cavity and paranasal sinuses. Improved outcome and altered prognostic factors with combined modality therapy. Cancer 1997; 80: 477-88. (R2/70)
   Google Scholar
• Cheung MMC, Chan JKC, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumour immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70-7. (R2/113)
   Google Scholar
• Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995; 13: 666-70. (R2/100)
   Google Scholar
• Corcoran MC, Eary J, Bernstein I, Press OW. Radioimmu-notherapy strategies for non-Hodgkin's lymphomas. Ann Oncol 1997; 8: 133-8. (L1)
   Google Scholar
• Press OW. Innovative new therapies for non-Hodgkin's lym-phomas: monoclonal antibodies and immunoconjugates. Edu-cational book of the 36th Annual Meeting of the American Society of Clinical Oncology; May 19–23, New Orleans; 2000. p. 328–37. (L1)[G5]
   Google Scholar
• Liu SY, Eary JF, Petersdorf SH, et al. Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J Clin Oncol 1998; 16: 3270-8. (P2/29)
   Google Scholar
• Witzig TE, Gordon LI, Cabanillas F, et al. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol 2002; 20: 2453-63. (C2/143)
   Google Scholar